OHSU Scientists Find Beta-Carotene Suppliments Fail To Improve Immune Function In HIV-Infected Patients

October 04, 1996

October 4, 1996

Contact: Julie Remington
503 494-8231

A number of studies in recent years have reported that beta-carotene supplements increase immune cells in HIV-infected patients. However a recent study by researchers at Oregon Health Sciences University found that beta-carotene supplements did not increase the immune cell counts in patients infected with HIV.

The study led by Gregg O. Coodley, M.D., associate professor of internal medicine at Oregon Health Sciences University, appeared in the journal AIDS in August, 1996. In the study Coodley and his co-authors concluded that supplementation with high doses of beta-carotene is not recommended for HIV-infected patients.

"Though high doses of beta carotene did not harm patients who are positive for HIV, our study showed that beta-carotene did not increase the immune cell counts in a statistically significant way," says Coodley. "Our earlier, 4-week study involving only 21 patients had shown that beta-carotene supplements in HIV-infected patients resulted in increased numbers of important white blood cells, called CD4 cells, that fight infection. However this expanded 3-month study involving 72 HIV-positive patients did not support those results. In this larger study we found no significant difference in the CD4 cell counts or any other immune parameters between the placebo group and the group receiving beta- carotene supplements."

Beta carotene is a natural compound occurring in plants and bacteria that is converted to Vitamin A in the body as needed. A growing literature has suggested that beta-carotene is associated with immune function. A number of epidemiological studies have suggested that low levels of beta-carotene in the blood are associated with an increased frequency of diseases such as lung, stomach, liver and breast cancers as well as coronary artery disease. However large scale intervention studies in which beta-carotene supplements were given to large numbers of patients have yielded mixed results. "Though the whole story on beta carotene and the immune system is not known yet, our larger study failed to demonstrate any benefit from beta-carotene supplementation in HIV-infected people," says Coodley. "Interestingly, these results were not affected whether the patient was in a subgroup that was taking antiretroviral drugs or not."

An HIV-infected person's CD4 cell count is used to track the progression of the disease. The official definition of AIDS is a CD4 count of 200 or less per deciliter of blood measured on two occasions. The normal CD4 count ranges from 800 to 1,200.

"The results of our larger study do not support the use of pharmacological supplementation with high doses of beta-carotene in HIV-infected patients," says Coodley.

Oregon Health & Science University

Related Coronary Artery Disease Articles from Brightsurf:

Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease
An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis--or GWAS--and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.

Oral radiography can reveal chronic coronary artery disease
A study found a link between carotid artery calcification observable in radiographs and coronary artery disease as well as several oral infections.

A new strategy to counter insulin damage in coronary artery disease
By studying blood vessel tissue from 674 patients, a research team has discovered how insulin contributes to the dysfunction of blood vessels in atherosclerosis, one of the most common chronic health conditions worldwide.

3D fusion imaging improves coronary artery disease diagnosis
A new technique that combines CT and MRI can bolster coronary artery disease diagnosis and help to define appropriate treatment for patients suffering from the disease, according to a new study.

Associations between vaspin levels and coronary artery disease
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0565, Lutfu Askin, Okan Tanriverdi, Hakan Tibilli and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider associations between vaspin levels and coronary artery disease.

Waist size, not body mass index, may be more predictive of coronary artery disease
For years, women have been told that weight gain could lead to heart disease.

Women with coronary artery wall thickness at risk for heart disease
The thickness of the coronary artery wall as measured by MRI is an independent marker for heart disease in women, according to a new study.

SPIE journal reports advances in use of 3D models in assessing coronary artery disease
In an article published in SPIE's Journal of Medical Imaging (JMI), researchers announce critical advances in the use of 3D-printed coronary phantoms with diagnostic software, further developing a non-invasive diagnostic method for Coronary Artery Disease (CAD) risk assessment.

E-cigarettes linked to heart attacks, coronary artery disease and depression
Concerns about the addictive nature of e-cigarettes -- now used by an estimated 1 out of 20 Americans -- may only be part of the evolving public health story surrounding their use, according to data being presented at the American College of Cardiology's 68th Annual Scientific Session.

Is guideline-recommended therapy for coronary artery disease more likely in Medicare Advantage?
Medicare Advantage is Medicare's managed-care alternative to traditional fee-for-service Medicare.

Read More: Coronary Artery Disease News and Coronary Artery Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.